Institutional & Family Asset Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$125K Hold
1,350
– – 0.02% 173
2024
Q1
$129K Hold
1,350
– – 0.02% 165
2023
Q4
$103K Hold
1,350
– – 0.02% 187
2023
Q3
$93.5K Hold
1,350
– – 0.02% 182
2023
Q2
$127K Hold
1,350
– – 0.02% 162
2023
Q1
$112K Hold
1,350
– – 0.02% 168
2022
Q4
$101K Hold
1,350
– – 0.02% 172
2022
Q3
$112K Hold
1,350
– – 0.02% 162
2022
Q2
$128K Hold
1,350
– – 0.02% 157
2022
Q1
$159K Hold
1,350
– – 0.02% 161
2021
Q4
$175K Hold
1,350
– – 0.03% 164
2021
Q3
$153K Hold
1,350
– – 0.02% 201
2021
Q2
$140K Hold
1,350
– – 0.02% 203
2021
Q1
$113K Hold
1,350
– – 0.02% 252
2020
Q4
$123K Hold
1,350
– – 0.03% 232
2020
Q3
$108K Hold
1,350
– – 0.03% 221
2020
Q2
$93K Hold
1,350
– – 0.02% 244
2020
Q1
$85K Hold
1,350
– – 0.02% 224
2019
Q4
$105K Hold
1,350
– – 0.02% 224
2019
Q3
$99K Hold
1,350
– – 0.02% 216
2019
Q2
$83K Hold
1,350
– – 0.02% 251
2019
Q1
$86K Hold
1,350
– – 0.02% 262
2018
Q4
$69K Hold
1,350
– – 0.02% 280
2018
Q3
$78K Hold
1,350
– – 0.02% 302
2018
Q2
$66K Hold
1,350
– – 0.01% 325
2018
Q1
$63K Buy
+1,350
New +$58.6K 0.01% 305

Other funds holding EW

Institutional & Family Asset Management's EW Position: Q2 2024 in Review

Institutional & Family Asset Management held its Edwards Lifesciences (EW) position steady in Q2 2024 at 1,350 shares worth $125K. The position accounts for 0.02% of the portfolio, ranked #173.

Institutional & Family Asset Management first reported a position in EW in Q1 2018 and has held it in 26 quarters since. The position peaked at $175K in Q4 2021. 1,297 funds tracked by Wall St. Rank hold EW as of Q2 2024.

  • Institutional & Family Asset Management held 1,350 shares of Edwards Lifesciences worth $125K as of Q2 2024.
  • Institutional & Family Asset Management left its Edwards Lifesciences share count unchanged in Q2 2024.
  • Edwards Lifesciences made up 0.02% of Institutional & Family Asset Management's portfolio in Q2 2024, its #173 holding.
  • Institutional & Family Asset Management first reported a position in Edwards Lifesciences in Q1 2018 and has held it in 26 quarters since.
  • Institutional & Family Asset Management's Edwards Lifesciences position peaked at $175K in Q4 2021.
  • 1,297 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2024.

Based on Institutional & Family Asset Management's 13F filing for Q2 2024, filed 5 Jul 2024.